Exchange: NYSE·Updated 04:00 AM EDT
News
all
press releases
GEHC vs. HAE: Which Stock Is the Better Value Option?
GEHC vs. HAE: Which Stock Is the Better Value Option?
Zacks
More News
AZENTA ANNOUNCES LEADERSHIP TRANSITION
AZENTA ANNOUNCES LEADERSHIP TRANSITION AZENTA ANNOUNCES LEADERSHIP TRANSITION PR Newswire BURLINGTON, Mass., Aug. 24, 2026 Current Director Dr. Martin Madaus Appointed Interim CEOCompany Reaffirms Previously Announced Fourth Quarter Fiscal 2026 Total Revenue GuidanceBURLINGTON, Mass., Aug. 24, 2026...
PR Newswire
These Stocks are Keeping the Heat Up
The market is once again rewarding companies that can produce a combination of real operating progress, identifiable catalysts and a credible path to growth, including NeOnc (NASDAQ:NTHI), Profusa (NASDAQ:PFSA), CorMedix (NASDAQ:CRMD), IP Strategy (NASDAQ:IPST), Haemonetics (NYSE:HAE), Heartflow (NASDAQ:HTFL), and FreeCast (NASDAQ:CAST).
24-7 Market News
Haemonetics Shares Hit New 52-Week High: What's Happening?
Shares of Haemonetics Corp (NYSE: HAE) are trading higher Tuesday afternoon following news of a significant commercial agreement.read more...
Benzinga
Here's Why Haemonetics (HAE) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks
Haemonetics (HAE) is a Top-Ranked Value Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks
HAE Stock Gains on Q1 Earnings & Revenue Beat, Fiscal '27 View Up
Haemonetics raises fiscal 2027 revenue guidance after Q1 earnings and sales beat, supported by Plasma growth and stronger cash generation.
Zacks
Haemonetics (HAE) Q1 2027 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
Haemonetics (HAE) Reliance on International Sales: What Investors Need to Know
Examine Haemonetics' (HAE) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.
Zacks
Haemonetics Corp Q1 Sales Increase
(RTTNews) - Haemonetics Corp (HAE) reported a profit for first quarter of $33.01 million...
Nasdaq News: Markets

Advertisement|Remove ads.